Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/MBIO stock hub

CSE/MBIO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/MBIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.8M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/MBIO

In the news

Latest news · CSE/MBIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/MBIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

127

Groups with data

Currency

AUD

Showing 127 of 127 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 9.4M
Exchange	Canadian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	CAD 7.8M
Price	CAD 1.07
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/MBIO
Website	https://www.mindbiotherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-70.49%
EV Earnings	-1.71x
P/B ratio	-4.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -5.5M
ROA	-970.5
ROCE	258.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-73.27%
Cagr3y	-83.53%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 485,024
Cash	CAD 384,483
Current Assets	CAD 525,690
Current Liabilities	CAD 2.5M
Debt	CAD 2M
Equity	CAD -1.9M
Interest Coverage	-15.02
Liabilities	CAD 2.3M
Long Term Assets	CAD -40,666
Long Term Liabilities	CAD -196,015
Net Cash	CAD -1.7M
Net Cash By Market Cap	CAD -21.35
Tangible Book Value	CAD -1.8M
Tangible Book Value Per Share	CAD -1.27
WACC	-0.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.21
Net Working Capital	CAD -189,112
Quick ratio	0.21
Working Capital	CAD -1.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-117,796.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-73.25%
200-day SMA	2.11
3Y total return	-99.55%
50-day SMA	1.04
50-day SMA vs 200-day SMA	50under200
All Time High	314
All Time High Change	-99.66%
All Time High Date	2023-05-08
All Time Low	0.5
All Time Low Change	114%
All Time Low Date	2025-11-25
ATR	0.1
Beta	-1.39
Beta1y	3.33
Beta2y	3.42
Ch YTD	-14.4
High	1.08
High52	6
High52 Date	2025-07-14
High52ch	-82.17%
Low	1.07
Low52	0.5
Low52 Date	2025-11-25
Low52ch	114%
Ma50ch	2.69%
Price vs 200-day SMA	-49.19%
RSI	49.08
RSI Monthly	30.59
RSI Weekly	43.98
Sharpe ratio	2.04x
Sortino ratio	4.26
Total Return	-117,796.91%
Tr YTD	-14.4
Tr1m	-1.83%
Tr1w	-12.3%
Tr3m	33.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -4.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,130,290%
Net Borrowing	-1,255.9
Shares Insiders	2.1%
Shares Out	7,283,063
Shares Qo Q	369.9%
Shares Yo Y	117,796.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	24,757.25x
Bv Per Share	-1.27
Ch1m	-1.83
Ch1w	-12.3
Ch1y	-73.25
Ch3m	33.75
Ch3y	-99.55
Ch6m	-50.23
Change	-2.73%
Change From Open	-0.93
Close	1.1
Days Gap	-1.82
Depreciation Amortization	29,561
Dollar Volume	2,697.5
Earnings Date	2026-05-13
EBIT	CAD -4.8M
EBITDA	CAD -4.8M
EPS	CAD -0.01
F Score	2
Financing CF	1,314,104
Fiscal Year End	June
Founded	2,021
Investing CF	9,115
Is Primary Listing	1
Last Earnings Date	2025-10-29
Last Report Date	2025-12-31
Last Split Date	2025-11-06
Last Split Type	Reverse
Ma150	1.69
Ma150ch	-36.61%
Ma20	1.08
Ma20ch	-0.56%
Net CF	315,767
Next Earnings Date	2026-05-13
Open	1.08
Position In Range	0
Price Date	2026-05-08
Relative Volume	0.1x
Share Based Comp	3,460,066
Tr6m	-50.23%
Volume	2,521

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/MBIO pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/MBIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/MBIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+117796.9%

Negative means the company is buying back shares.

Technical

CSE/MBIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.1

Neutral momentum band

Price vs 200-day MA

-49.2%

50/200-day relationship not available

Beta (5Y)

-1.39

Less volatile than the market

Sharpe ratio

2.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/MBIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/MBIO stock rating?

cse/MBIO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/MBIO analysis?

The full report lives at /stocks/cse/MBIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/MBIO?

The latest report frames cse/MBIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/MBIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.